MarketLens
Sign Up

Hims & Hers's GLP-1 Revenue Surge Erodes Core Profitability

2 months ago
SHARE THIS ON:

Hims & Hers's GLP-1 Revenue Surge Erodes Core Profitability

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

SHARE THIS ON:

Related Articles

Category

You may also like

Stock News•2 months ago

Hims & Hers Health's Next Act: Making Its Own Drugs Again

Hims & Hers Health's 2Q revenue rose 38% to $753.2M, and FY outlook was raised to $3.1–$3.3B, after branded GLP-1 distribution drove growth. Gross margin fell 6 points sequentially to 64%, pressuring ...
Stock News•3 months ago

Hims & Hers Health: The Market Still Doesn't Get It

Hims & Hers Health expanded internationally via the $1.15B Eucalyptus acquisition, adding 850K customers and ~$450M ARR, while a $400M JPMorgan facility supports GLP-1 expansion without equity dilutio...
Stock News•3 months ago

As Employers Drop Obesity Drug Coverage, Hims & Hers Could Be the Winner

Hims & Hers could benefit as employers drop obesity drug coverage, per a market analysis. The healthcare sector rose ~6% over the past month, led by Big Pharma but also lifting smaller firms.

Breaking News

View All →

No topics available at the moment

Top Headlines

View More →
Stock News•54 minutes ago

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Alphabet Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GOOGL, GOOG

Stock News•1 hour ago

Why the Market Dipped But Meta Platforms (META) Gained Today

Stock News•1 hour ago

Nvidia in 5 Years: Where the Stock Could Be Headed

Stock News•2 hours ago

UK finance minister Healey to target online marketplaces in tax crackdown, The Times reports

Stock News•2 hours ago

Character.AI owes Google and Big Law firms nearly $7M, court filings show